Feasibility of MR-guided stereotactic ablative body radiotherapy of lymph node oligometastases

被引：0
|
作者：
Batumalai, V. [1 ]
Crawford, D. [1 ]
Pagulayan, C. [1 ]
Hogan, L. [1 ]
Jelen, U. [1 ]
Loo, C. [1 ]
Dunkerley, N. [1 ]
Picton, M. [1 ]
Geddes, L. [1 ]
Alvares, S. [1 ]
Sampaio, S. [1 ]
Heinke, M. [1 ]
Twentyman, T. [1 ]
Jameson, M. [1 ]
de Leon, J. [1 ]
机构：
[1] GenesisCare, Radiat Oncol, Sydney, NSW, Australia
来源：
RADIOTHERAPY AND ONCOLOGY | 2022年 / 170卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO-0649
引用
收藏
页码：S584 / S584
页数：1
相关论文
共 50 条
  • [11] Stereotactic Ablative Body Radiotherapy for the Treatment of Spinal Oligometastases
    Chang, J. H.
    Gandhidasan, S.
    Finnigan, R.
    Whalley, D.
    Nair, R.
    Herschtal, A.
    Eade, T.
    Kneebone, A.
    Ruben, J.
    Foote, M.
    Siva, S.
    CLINICAL ONCOLOGY, 2017, 29 (07) : E119 - E125
  • [12] Stereotactic Ablative Body Radiotherapy to Treat Colorectal Oligometastases
    Saxby, H.
    Chandy, E.
    Phillips, I.
    Ezhil, V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E173 - E174
  • [13] Phase I Trial of Stereotactic MR-guided Online Adaptive Radiotherapy for Ovarian Oligometastases
    Henke, L.
    Green, O.
    Curcuru, A.
    Mutic, S.
    Markovina, S.
    Schwarz, J.
    Grigsby, P.
    Robinson, C.
    Chundury, A.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S817 - S818
  • [14] Treatment patterns for adrenal metastases in the era of MR-guided stereotactic ablative radiotherapy
    van Vliet, C.
    Schneiders, F.
    Engelsman, A.
    Hashemi, S.
    Bahce, I.
    Haasbeek, C.
    Bruynzeel, A.
    Lagerwaard, F.
    Palacios, M.
    Becker-Commissaris, A.
    Slotman, B.
    Dickhoff, C.
    Senan, S.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S572 - S573
  • [15] Feasibility of split-course stereotactic ablative radiotherapy for oligometastases
    Paik, Eun Kyung
    Kim, Mi-Sook
    Seo, Young-Seok
    Jang, Won Il
    Kang, Jin-Kyu
    Cho, Chul-Koo
    Yoo, Hyung Jun
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (06) : 548 - 554
  • [16] Feasibility of MR-guided stereotactic body radiotherapy in 5, 2 or 1 fractions for prostate cancer
    Mohajer, J.
    Dunlop, A.
    Mitchell, A.
    Nill, S.
    Oelfke, U.
    Tree, A.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S290 - S290
  • [17] Feasibility of Stereotactic MR-Guided Adaptive Radiotherapy in Localized Prostate Cancer
    Mustafayev, T. Z.
    Atalar, B.
    Gungor, G.
    Sengoz, M.
    Abacioglu, U.
    Ozyar, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E916 - E916
  • [18] MR-guided stereotactic radiotherapy of infra-diaphragmatic oligometastases: Evaluation of toxicity and dosimetric parameters
    van Overeem Felter, Mette
    Moller, Pia Krause
    Josipovic, Mirjana
    Bekke, Susanne Norring
    Bernchou, Uffe
    Serup-Hansen, Eva
    Madsen, Kasper
    Parikh, Parag J.
    Kim, Joshua
    Geertsen, Poul
    Behrens, Claus P.
    Vogelius, Ivan R.
    Pohl, Mette
    Schytte, Tine
    Persson, Gitte Fredberg
    RADIOTHERAPY AND ONCOLOGY, 2024, 192
  • [19] Ablative Stereotactic MR-Guided Adaptive Radiotherapy in Patients with Infra -Diaphragmatic Oligometastatic Disease
    Akdemir, E. Y.
    Chuong, M. D.
    Herrera, R.
    Kaiser, A.
    Kutuk, T.
    La Rosa, A.
    Mittauer, K. E.
    Bassiri-Gharb, N.
    Tolakanahalli, R. P.
    Gutierrez, A.
    Mehta, M. P.
    Kotecha, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E213 - E214
  • [20] MR-Guided Liver Stereotactic Body Radiotherapy (SBRT): To Adapt, or Not to Adapt?
    Kuczmarska-Haas, A.
    Yadav, P.
    Burr, A.
    Witt, J. S.
    Blitzer, G. C.
    Bassetti, M. F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S146 - S147
12345